Dermacyd Teen Care Tangerina Mix - Compatibility
Phase 3
Completed
- Conditions
- Hygiene
- Registration Number
- NCT00761800
- Lead Sponsor
- Sanofi
- Brief Summary
The purpose of this study is to demonstrate the absence of irritation potential (primary dermal irritability and cumulated dermal irritability) and allergy (sensibilization) of the product Dermacyd Teen Care Tangerina Mix.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 51
Inclusion Criteria
- Phototype Skin I,II, III e IV
- Integral skin test in the region
Exclusion Criteria
- Lactation or gestation
- Use of Anti-inflammatory and/or immuno-Supression drugs 1 month before the study
- Personal history of atopy
- History of sensitivity or irritation for topic products
- Active cutaneous disease
- Use of new drugs or cosmetics during the study
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method The absence of primary and accumulated dermal irritability will be evaluated using International Contact Dermatitis Research Group (ICDRG) scale. Throughout the study
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of dermal irritation and sensitization in adolescents using Dermacyd Teen Care Tangerina Mix?
How does the formulation of Dermacyd Teen Care Tangerina Mix compare to standard-of-care hygiene products in terms of dermal compatibility?
Are there specific biomarkers that indicate individual susceptibility to dermal reactions from hygiene products like Dermacyd Teen Care Tangerina Mix?
What are the potential adverse events associated with prolonged use of Dermacyd Teen Care Tangerina Mix in adolescent populations?
What are the key components of Dermacyd Teen Care Tangerina Mix and how do they interact with the skin barrier in Phase 3 trials?
Trial Locations
- Locations (1)
Sanofi-Aventis Administrative Office
🇧🇷Sao Paulo, Brazil
Sanofi-Aventis Administrative Office🇧🇷Sao Paulo, Brazil